Disclaimer

The information provided in this website should not be construed as an offer to sell to any person, or a solicitation of any offer to buy from any person, in any jurisdiction, any interests in any products or funds, nor should it be regarded as an investment product or financial advice or be relied upon for any purpose.

While CLSA Capital Partners Limited, its subsidiaries and their respective directors, officers, employees, agents, contractors and advisers (collectively, the "CLSA Capital Partners Group") use reasonable efforts to obtain information from sources believed to be reliable, the CLSA Capital Partners Group does not make any representation or warranty as to the truth, accuracy or completeness of the information (including statements of opinion or expectation) provided in this website or as to the achievement or reasonableness of any future projections, estimates, prospects or returns or any of the assumptions underlying them. The CLSA Capital Partners Group shall not have any liability (whether arising from negligence or otherwise) for any representations (expressed or implied) contained in, or for any omissions from, the information on this website. None of the information provided in this website has been approved by any governmental or other authority in any jurisdiction.

The investments described in this website were selected to illustrate types of investments that the funds sponsored by the CLSA Capital Partners Group may pursue. Therefore, these investments are not indicative of future investments or the actual or anticipated performance of the funds, sponsored by the CLSA Capital Partners Group, through which such investments were made, nor should such investments be viewed as representative of the portfolio of investments held by such funds.

The content provided in this website is, unless otherwise specified, directed at residents of the United States and not intended for distribution to, or use by, any person or entity in any jurisdiction where such distribution or use would be contrary to law or regulation or which would subject the CLSA Capital Partners Group to any registration or other requirement within such jurisdiction. Access to this website may be limited with respect to any person, geographic region or jurisdiction, and the information contained in this website is subject to change without notice.


Disclosure

In accordance with the Financial Instruments and Exchange Law of Japan, certain information is made available for Japanese investors upon request. Please email us at Capital.Partners@clsa.com.

免責事項

当サイトに掲載しているCLSA Capital Partners Limitedの運用するファンド（以下「ファンドという。」）に関する情報は、投資に対する助言または販売の勧誘を目的としたものではありません。またこれらの情報は特定の金融商品等の売買の推奨又は投資助言を意図したものではありません。

CLSAの関連会社、並びにその役員、管理者、従業員、代理人、契約者及び助言者（以下、「CLSAキャピタルパートナーズグループ」という。）は、当サイトに掲載する内容（意見や将来の見通しについての記述を含む）に関しては万全を期しておりますが、その公正性、正確性及び完全性、並びに将来の業績、予測、及びパフォーマンスの実現性や合理性に関する記述又はその表現について、表明又は保証するものではありません。またCLSAキャピタルパートナーズグループは当サイトで掲載している情報、又はその内容における完全性及び正確性を、明示的にも黙示的にも保証しておりません。当サイトの内容は関係官庁に承認されたものではありません。

当サイトに記載された投資案件は、CLSAキャピタルパートナーズグループが過去に取り組んだ投資の一例として選択されたものであり、CLSAキャピタルパートナーズグループが将来取り組む投資の内容及びそれらの業績の予測を示すものではありません。当サイトに掲載されている情報は、その情報の配布又は使用がその地域や国の法律や規制の違反となるような地域や国、又はファンド及びCLSAキャピタルパートナーズグループが登録義務を負うような地域や国の個人または組織への配布又はこれらによる使用を意図したものではありません。


English 简体中文

Investments

Current Portfolio Previous Portfolio
FortyTwo

FortyTwo is a fast-growing, highly reputable e-commerce home furnishing brand in Singapore. Established more than a decade ago, it has grown to become the dominant market leader in its segment and is also ranked amongst the top e-commerce websites in Singapore. It currently offers more than 20,000 items across a wide range of furniture, home decor and lifestyle products.

Website: www.fortytwo.sg

ACT Genomics

Founded in 2014, ACTG provides optimal cancer treatment plans, cancer relapse and drug resistance monitoring as well as cancer risk assessment and immunotherapy evaluation through DNA sequencing-based technology. The Company achieves precise cancer genetic variants detection with minimum tumour samples, and delivers to every cancer patient personalised genomic, information-based treatment plans through a cutting-edge NGS platform, medical reports and integrated services. ACTG also provides comprehensive data analysis on cancer genomics applying Artificial Intelligence and integrates genomic databases with Asia specific genome profiling.

Website: www.actgenomics.com

Press Release
CLSA Capital Partners’ ARIA V invests in ACT Genomics, a leading DNA sequencing-based cancer solution provider in Asia26 September 2018

Azoya

Azoya is a leading turnkey e-commerce solutions provider and retail operator, which assists global retailers in tapping into China via cross-border e-commerce model and establishes the next-generation cross-border trading platform. With the all-encompassing services and dedicated specialist teams, Azoya has already successfully established strategic partnerships with over 35 international retailers across 11 countries since 2013, making Azoya as one of the leaders and fastest growing player in cross-border e-commerce in China.

Website: www.azoyagroup.com

Press Release
CLSA Capital Partners’ ARIA IV invests in Azoya, a leading cross-border e-commerce solutions provider and retail operator in China.6 March 2017

Gaia Group

Founded in 2000, Gaia Group Holdings Limited (“Gaia”) is a well-established, multi-brand restaurant group based in Hong Kong operating more than 30 restaurants in Hong Kong, Shanghai, Beijing and Bangkok currently. Restaurant brands in its portfolio include Gaia, Isola,Greyhound Café, Wang Jia Sha, Petite House, Glasshouse, Townhouse, Greenhouse, Joia, Ivy and Bene all located in prime locations.

Website: www.gaiagroup.com.hk

Holisol Logistics

Based in Delhi, Holisol provides holistic supply chain solutions which include Fulfilment Centre (FC) solutions to E-commerce businesses including designing, setting up and operating FCs; last-mile delivery solutions to online and offline brands and customised packaging and shipping solutions & services to automotive industries.

Holisol was founded in 2009 by Rahul Dogar, Naveen Rawat and Manish Ahuja with a view to providing multi-channel logistic solutions to E-commerce and bricks & mortar retailers. Holisol manages 600,000 sq. ft of FCs across 14 locations, which makes it one of the leading independent E-commerce logistics players in India.

Website: www.holisollogistics.com

Press Release
CLSA Capital Partners’ ARIA IV Funds invest US$10 million in India’s Holisol Logistics16 Dec 2015

PT Arena Gourmet

Established in 2002, PT Arena Gourmet (“Arena”) was started by a young team of three dynamic entrepreneurs.

Today, the company operates a chain of 25 casual dining restaurants in Jakarta, Indonesia. Its well-known brands include Penang Bistro (Malaysian), Seribu Rasa (South East Asian) and HK Café (Hong Kong) and augmented by newer brands Tatsuya (Teppanyaki), Miyagi (Japanese) and La Hoya (Mexican). All these brands focus on the middle market consumers.

Besides serving dine-in, Arena also hosts corporate events and private gatherings.

Website: www.arenacorp.com

Coco Healthcare Products Co., Ltd.

Based in Hangzhou, Coco is one of China’s fastest growing companies in the consumer goods sector targeting the country’s rapidly aging population. Coco is a market leader for adult diapers in both traditional retail and online e-commerce sales. Based on the combined notion of “comfortable and considerate”, its “Coco” brand products are distributed nationwide across China. Coco is also China’s largest exporter of baby diapers, providing dedicated private label and ODM/OEM solutions to major regional and international customers.

Website: www.cocohealthcare.com/

Press Release
CLSA Capital Partners’ ARIA IV Funds invest RMB 150 million in China’s Coco Healthcare11 May 2015

Nobel Hygiene Private Limited

Based in Mumbai, Nobel Hygiene Private Limited is India’s first and leading manufacturer of adult and baby diapers which manufactures diapers and other personal hygiene products in its own facility and sells under its own brands through a vast distribution network. Founded more than a decade ago by Kamal Johari, who has extensive experience of dealing in FMCG businesses in India, Nobel is a leader in the adult diaper category selling under the brand name ‘FRIENDS’ and an emerging player in the baby diaper category selling under the brand name ‘TEDDYY’.

Website: www.nobelhygiene.com/

Press Release
CLSA Capital Partners’ ARIA IV Funds invest US$ 10 million in India’s Nobel Hygiene26 Feb 2015

Livpure Private Limited

Livpure Private Limited (formerly Luminous Water Technologies), which is based in Gurgaon, India, owns Livpure, the fastest growing reverse osmosis ("RO") water purifier brands in the Indian domestic market. Livpure is engaged in the design, manufacturing, distribution and servicing of water purifier and water filter systems for home, residential and commercial use. Since its launch in 2012, "Livpure" has already attained a prominent position in the RO segment.

Increasing health awareness and the demand for pure drinking water in India as well as rising disposable incomes have created opportunities for companies with reliable water purification systems to establish strong market positions.

Website: www.livpurewater.com

Press Release
CLSA Capital Partners’ ARIA IV Funds invest an aggregate of INR 550 million (US$ 9.2 million) in Luminous Water Technologies26 July 2013